Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Duncan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Biopharmaceutical Statistics|September 12, 2024
Robust safety monitoring and signal detection using alternatives to the standard poisson distributionBenjamin Duncan
Epilepsia|February 27, 2009
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizuresJesus Eric Piña-Garza, Douglas R Nordli, Dietz Rating, et al.
Clinical Therapeutics|November 25, 2010
Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeksJesus Eric Piña-Garza, Jimmy Schiemann-Delgado, Haichen Yang, et al.
Arthritis Research & Therapy|November 29, 2015
Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activityJanet Pope, Clifton O Bingham, Roy M Fleischmann, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 9, 2025
Contact Transfer Epitaxy of Halide PerovskitesHongyu Sun, Linde M van de Ven, Benjamin Duncan, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Process Mining and Ethnography Study of Medication Reconciliation TasksVaishak Ramesh Vellore, M Adela Grando, Benjamin Duncan, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb studyMark C Genovese, Roy Fleischmann, Daniel Furst, et al.
Journal of the American Chemical Society|September 29, 2020
Cracking under Internal Pressure: Photodynamic Behavior of Vinyl Azide Crystals through N<sub>2</sub> ReleaseDylan J Shields, Durga Prasad Karothu, Karthik Sambath, et al.
Arthritis Research & Therapy|November 17, 2015
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis populationMichael E Weinblatt, Roy Fleischmann, Ronald F van Vollenhoven, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Multi-Method Study of Electronic Health Records WorkflowsAdela Grando, Areti Manataki, Stephanie K Furniss, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|September 12, 2024
Robust safety monitoring and signal detection using alternatives to the standard poisson distributionBenjamin Duncan
Epilepsia|February 27, 2009
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizuresJesus Eric Piña-Garza, Douglas R Nordli, Dietz Rating, et al.
Clinical Therapeutics|November 25, 2010
Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeksJesus Eric Piña-Garza, Jimmy Schiemann-Delgado, Haichen Yang, et al.
Arthritis Research & Therapy|November 29, 2015
Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activityJanet Pope, Clifton O Bingham, Roy M Fleischmann, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 9, 2025
Contact Transfer Epitaxy of Halide PerovskitesHongyu Sun, Linde M van de Ven, Benjamin Duncan, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Process Mining and Ethnography Study of Medication Reconciliation TasksVaishak Ramesh Vellore, M Adela Grando, Benjamin Duncan, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb studyMark C Genovese, Roy Fleischmann, Daniel Furst, et al.
Journal of the American Chemical Society|September 29, 2020
Cracking under Internal Pressure: Photodynamic Behavior of Vinyl Azide Crystals through N<sub>2</sub> ReleaseDylan J Shields, Durga Prasad Karothu, Karthik Sambath, et al.
Arthritis Research & Therapy|November 17, 2015
Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis populationMichael E Weinblatt, Roy Fleischmann, Ronald F van Vollenhoven, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Multi-Method Study of Electronic Health Records WorkflowsAdela Grando, Areti Manataki, Stephanie K Furniss, et al.
Pageof 2